7Baggers
 Intensity Therapeutics dips 5%, prices $3M offering  MSN Sun, 21 Sep 2025 08:25:59 GMT
 published on: 2025-09-17 18:22:01  خودرو بانک Wed, 17 Sep 2025 14:56:46 GMT
 published on: 2025-09-17 05:42:51  newser.com Wed, 17 Sep 2025 10:42:51 GMT
 published on: 2025-09-16 03:56:43  newser.com Tue, 16 Sep 2025 08:56:43 GMT
 published on: 2025-09-15 14:36:55  خودرو بانک Mon, 15 Sep 2025 11:07:04 GMT
 published on: 2025-09-14 15:15:21  newser.com Sun, 14 Sep 2025 20:15:21 GMT
 published on: 2025-09-13 03:42:25  Newser Sat, 13 Sep 2025 08:42:25 GMT
 published on: 2025-09-12 14:49:46  Newser Fri, 12 Sep 2025 19:49:46 GMT
 Intensity Therapeutics Pauses Enrollment in INVINCIBLE-4 Study  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 intensity therapeutics: invincible-4 tnbc trial update  MarketScreener Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 09:54:46  Newser Mon, 08 Sep 2025 14:54:46 GMT
 published on: 2025-09-08 05:12:13  Newser Mon, 08 Sep 2025 10:12:13 GMT
 published on: 2025-09-05 01:24:07  Newser Fri, 05 Sep 2025 06:24:07 GMT
 published on: 2025-09-05 01:24:07  Newser Thu, 04 Sep 2025 06:16:44 GMT

Intensity Therapeutics
(NASDAQ:INTS) 

INTS stock logo

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon,...

Founded: 2012
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends